期刊文献+

2型糖尿病合并冠心病危险因素的临床研究 被引量:19

Clinical Study on the Risk Factors in Type 2 Diabetics Combined with Coronary Heart Disease
在线阅读 下载PDF
导出
摘要 目的:探讨2型糖尿病(T2DM)患者导致冠心病(CHD)的危险因素。方法:将已确证为T2DM的85例患者,根据其是否并发CHD分为2组,其中单纯T2DM组44例,T2DM并发CHD组41例。了解并检测2组患者性别、年龄、体质量、病程、体质量指数(BMI)、收缩压(SBP)、舒张压(DBP)、血糖(FBG、P2BG)、胰岛素(FINS、PINS)、糖化血红蛋白(HbA1c)、胆固醇(TC、HDL-C、LDL-C、VLDL-C)、甘油三酯(TG)、血尿酸(UA)、胰岛素抵抗指数(HOMA-IR)和24h微量白蛋白排泄率(UAE)、纤维蛋白原(FIB)、C-反应蛋白(S-CRP)及下肢动脉狭窄程度。结果:(1)2组在HbA1c、FBG、TG、TC、HDL-C、FINS、UMA、PINS、FIB、S-CRP方面差异无统计学意义(P>0.05)。(2)2组在病程、BMI、SBP、DBP、P2BG、LDL-C、UA、HOMA-IR、P2BG/FBG方面差异有统计学差异(P<0.05)。结论:病程、BMI、DBP、P2BG、LDL-C、HOMA-IR是T2DM并发CHD的高危临床因素,必须予以早期防治。 Objective: To explore the risk factors in type 2 diabetics combined with coronary heart disease. Methods: Eighty-five patients with type 2 diabetes mellitus were divided into diabetes combined with coronary heart disease group (41 cases) and simple diabetes group (44 cases). Data of gender, age, weight, duration, BMI, SBP, DBP, FBG, P2BG, FINS, PINS, HbA1c, TC, HDL-C, LDL-C, VLDL-C, TG, UA, HOMA-IR, UAE, FIB, S-CRP and strictured degree of low extremity artery in the two groups were compared and analyzed. Results:(1) There was no significant difference in HbA1c, FBG, TG, TC, HDL-C, FINS, UMA, PINS, FIB and S-CRP between two groups (P 〉 0.05). (2) There was a significant difference in duration, BMI, SBP, DBP, P2BG, LDL- C, UA, HOMA-IR and P2BG/FBG between two groups (P 〈 0.05). Conclusion: The risk factors in type 2 diabetics combined with coronary heart disease include duration, BMI, DBP, P2BG, LDL-C, HOMA-IR and P2BG/FBG. Type 2 diabetics combined with coronary heart disease should be treated as early as possible.
出处 《天津医药》 CAS 北大核心 2006年第9期607-609,共3页 Tianjin Medical Journal
关键词 糖尿病 2型 冠状动脉疾病 危险因素 diabetes mellitus, type 2 coronary disease risk factors
  • 相关文献

参考文献6

  • 1Haffner SM,Miettinen H.Insulin resistance implications for type Ⅱ diabetes mellitus and coronary heart disease.Am J Med,1997,103:152
  • 2Spanheimer RG.Reducing cardiovascular risk in diabetes:which factors to modify first? Cardiovasc Risk Diabetes,2001,109:26-36
  • 3路影,杨华章.糖尿病合并高血压治疗进展[J].国外医学(内分泌学分册),2004,24(6):391-394. 被引量:33
  • 4Brun E,Zoppin G,Zamboni G,et al.Glucose instanility is associated with a high level of circulating P-selection.Diabetes,2001,24:1685
  • 5Hanefeld M,Fischer S,Julius U,et al.The DIS group risk factors for myocardial infarction and death in newly detected NIDDM; The Diabetes intervention study,17-year follow-up.Diabetologia,1996,39:1577-1583
  • 6李赟,刘江华.波动性高血糖与糖尿病大血管并发症[J].国外医学(内分泌学分册),2004,24(6):400-401. 被引量:29

二级参考文献36

  • 1Uehara MH, Kohlmann NE,Zanella MT,et al. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab, 2001,3: 319-325.
  • 2Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA, 2003,289: 2560-2572.
  • 3The STOP-NIDDM Trial. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA, 2003,290: 486-494.
  • 4Pahor M. Therapeutic benefits of ACE inhibitor and other antihypertensive drugs in patients with type 2 diabetes. Diabtes Care,2000,23:888-892.
  • 5Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New Engl J Med,2001,345:851-860.
  • 6Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001,345: 861-869.
  • 7Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.Am J Physiol Endocrinol Metab,2001,281 :E924-E930.
  • 8Quagliaro L, Ros DA, Roberto DR, et al. Effects of intermittent high glucose concentrations at intracellular level in HUVECs. Diabetes, 2002,51(Suppl 2): A510.
  • 9The DECODE study group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Associatinn diagnostic criteria. Lancet,1999,354: 617-621.
  • 10Brun E,Zoppini G,Zamboni C,et al. Glucose instanility is associated with a high level of circulating p-selectin. Diabetes Care,2001,24:1685.

共引文献60

同被引文献130

引证文献19

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部